CLAT 2020: SC lets one COVID-19-affected student appear for test

One affected student who moved the Supreme Court will give the examination in a separate isolation room in the examination centre.

Moneycontrol News

September 28, 2020 / 12:34 PM IST

The Supreme Court, on September 28, allowed one Coronavirus-affected candidate to appear for the Common Law Admission Test (CLAT) 2020 in an isolation room.

CLAT 2020, scheduled for September 28, is the entrance exam for entry into the 22 law universities of the country.

Responding to a petition filed by an COVID-19 affected law aspirant, an SC bench led by Justice Ashok Bhushan said that only this one student will be allowed to appear for CLAT 2020 via an isolation room.

The apex court in its final order has said that the one student will be permitted to take the examination in a separate isolation room. Arrangements for this will have to made by the examination authorities.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show